20.01.2012Avila Announces FDA Allowance of Partner Clovis Oncology’s IND Application

Avila Announces FDA Allowance of Partner Clovis Oncology’s IND Application for CO-1686, an Oral EGFR Mutant-Selective Inhibitor - Triggers $4 Million Milestone Payment to Avila

Press Release
19.01.2012Advent Life Sciences Fund I welcomes additional investor

Advent Life Sciences is pleased to welcome the SNCI as an investor in Advent Life Sciences Fund I (ALSF I).  This now brings ALSF I to a final close of just under £100m.

Press Release
04.01.2012Cornerstone Therapeutics Acquires Cardiokine

Cornerstone acquires worldwide rights to investigational therapy for hyponatremia

Press Release
30.12.2011Amsterdam Molecular Therapeutics Announces 2.5 Million Equity Raise

Press Release
18.11.2011FDA approves Erwinaze to treat a form of leukemia

Press Release
18.11.2011EUSA Pharma Announces FDA Approval Of Orphan Drug ERWINAZE™ For Treatment Of Acute Lymphoblastic Leukemia

Press Release
18.11.2011Biocartis completes EUR 71 million (USD 100 million) Series C Fund Raising

Press Release
18.10.2011Cellnovo receives 2011 Best MedTech Fundraiser Award

Press Release
04.10.2011Frost & Sullivan has announced Cellnovo the winner of its 2011 European Technology Innovation Award in Diabetes Care

Press Release
19.09.2011Cellnovo Receives CE Mark Approval for World's First Mobile Diabetes Management System

Press Release